OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Nephrology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
A UMOD variant with intermediate effects	1050
Mentorship in the lives of scholars	982
Kidney health within the broader non-communicable disease agenda	595
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	564
The changing landscape of kidney health and disease in Africa	549
The GLP-1 receptor agonist revolution comes to nephrology	479
Disaster preparedness for patients with kidney disease	450
Treatment of chronic kidney disease in older populations	400
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	375
Engineered CAR macrophages target kidney inflammation	342
CD93 and endothelial cells as therapeutic targets in podocytopathies	300
Making advance care planning easier for adults with kidney disease and their clinicians	286
Role of the gut microbiota in the pathogenesis of IgA nephropathy	267
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	264
Uropathogen and host responses in pyelonephritis	251
Author Correction: Salt and chronic kidney disease	239
Designing acute kidney injury clinical trials	228
Vaccination in patients with kidney failure: lessons from COVID-19	212
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	211
A single-cell atlas of DKD treatment responses	210
Genetic determinants of urine and plasma metabolite levels	194
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	188
Beyond state borders: transforming dialysis care for undocumented immigrants	174
The continued odyssey to unravel the secrets of kidney inflammation	170
Consideration of sex differences is necessary to achieve health equity	163

Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	162
Roles of sensory receptors in non-sensory organs: the kidney and beyond	144
Complosome — the intracellular complement system	141
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	140
Phosphate sensing via PTC glycolysis	129
Reducing preventable acute kidney injury in a hospital setting	126
Mutational signatures of ccRCC vary between geographical regions	125
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	113
Informing clinical decision making during a pandemic — a call for better preparedness	112
The effects of sex hormone therapy on kidney function	111
Clonal haematopoiesis and AKI	104
20 years of Nature Reviews Nephrology	103
The impact of social determinants of health on acute kidney injury	98
The roles of hyaluronan in kidney development, physiology and disease	98
Aquaporin water channels: roles beyond renal water handling	98
Increasing diversity and inclusion in nephrology clinical trials	95
Menopause and chronic kidney disease	92
Design of a renal-sparing antifungal	90
Tertiary lymphoid organs contribute to kidney allograft rejection	89
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	89
Heat and health inequity: acting on determinants of health to promote heat justice	89
Salt substitution: opportunities and challenges for nephrology	87
Environmental stewardship and health systems: Indigenous-centred reflections	87
Benefits of actin cytoskeleton stabilization	83
Identification of erythropoietin-producing cells	83
From fat to filter: the effect of adipose tissue-derived signals on kidney function	82
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	79
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	78
Treatment of SLE with anti-CD19 CAR-T cells	76
Long-term health outcomes associated with hydration status	74
Neutrophils and NETs in kidney disease	74
Pathological mechanisms of kidney disease in ageing	73
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	71
The role of complement in kidney disease	71
A label-free optical analysis for molecular nephrology	70
A golden year of innovative kidney disease therapeutics	69
Reaping the rewards of mechanistic discovery in glomerular disease	66
MSC therapy for diabetic kidney disease and nephrotic syndrome	64
A pathway of osmotic stress-induced necroptosis	63
The evolving landscape of immune-mediated glomerular diseases	63
Combination therapy for kidney disease in people with diabetes mellitus	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	59
Ketogenic diet benefits in critically ill patients with sepsis	58
Atmospheric stressors and kidney diseases	58
Network medicine: an approach to complex kidney disease phenotypes	58
Quality-oriented diet therapy for chronic kidney disease	57
Long COVID and the kidney	57
Consequences of famine and malnourishment on kidney health	57
The cilia mechanosensation debate gets (bio)physical	52
PDGFRβ CAR T cells improve fibrosis in kidney disease models	51

Role of the cGAS–STING pathway in systemic and organ-specific diseases	49
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	49
Consequence of microvascular inflammation in transplantation	48
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	48
Community power building to reduce inequities in access to health care	47
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	46
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	45
Mechanism of B cell survival in lupus nephritis	44
Dietary protection of proximal tubules in diabetes	44
Steps forward in the treatment of IgA nephropathy	43
Gene therapy in a model of nephrotic syndrome	43
Metabolic alterations in hereditary and sporadic renal cell carcinoma	43
The kidney is a novel target of metformin	43
Mannose as a driver of γδ T cell kidney infiltration	43
Chronic cardiovascular–kidney disorder: a new conceptual framework	42
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	42
A guide to gene–disease relationships in nephrology	42
Wearable biosensor can detect impaired kidney drug clearance	41
Generation of self-assembling kidney progenitor assembloids	39
Targeting IL-1Ra to attenuate fungal infection	39
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	38
The genetics of hypertension	37
Born too soon: lifelong kidney risks and the importance of early intervention	37
Epithelial cell states associated with kidney and allograft injury	36
Multifaceted innovations needed to advance transplant nephrology	36
Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management	35
Role of necroptosis in kidney health and disease	34
Derivation of collecting duct organoids	34
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	34
Fasting induces structural and functional changes in the peritoneal membrane	34
Strategies to achieve gender equity in nephrology	33
Insights into the impact of pregnancy on kidney disease	33
The increasing burden of mild and moderate anaemia in CKD	32
Green nephrology: from evidence to action	29
Leveraging data as a patient–scientist: frustrations and opportunities	29
Author Correction: Therapeutic advances in COVID-19	29
The impact of intrauterine growth restriction and prematurity on nephron endowment	29
From big data to smart decisions: artificial intelligence in kidney risk assessment	29
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects	28
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	28
Renal nerves in physiology, pathophysiology and interoception	28
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	27
Acute kidney injury in patients with burns	27
A guide to uraemic toxicity	27
Fibroblast activation and heterogeneity in fibrotic disease	26
The immunology of sepsis: translating new insights into clinical practice	26
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	25
Switching off SOX9 for epithelial recovery after AKI	24
Digital determinants of health: opportunities and risks amidst health inequities	24
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	23
Collagen formation, function and role in kidney disease	23